Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Stem Cell Therapies and Cellular Medicine Stem cell therapies represent another area of regenerative medicine that shares some therapeutic applications with BPC-157 and TB-500
Cardiovascular Outcomes# EXSCEL Trial (Exenatide)# The EXSCEL trial (Holman et al., NEJM 2017) enrolled 14,752 patients with type 2 diabetes (73.1% with prior cardiovascular disease) and followed them for a median of 3.2 years: Primary MACE endpoint : HR 0.91 (95% CI 0.83-1.00), p=0.06 for superiority Met non-inferiority but narrowly missed superiority (p=0.06) All-cause mortality was reduced by 14% (HR 0.86, p=0.016) in a secondary analysis EXSCEL confirmed cardiovascular safety but did not prove cardiovascular benefit -- a critical distinction
"Serum folate and chronic fatigue syndrome"
Mech Ageing Dev 1987
US$ 24.56
US$ 29.39
US$ 22.21
US$ 23.80
US$ 26.35
US$ 26.90
US$ 24.16
